technology - International Biopharmaceutical Industry

Volume 5 Issue 3

The Evolving Landscape of Academic Research Integrity

According to Retraction Watch, over 250 papers regarding COVID-19 published since the start of the pandemic have since been retracted. While retractions are an acknow...

12 October 2022 Volume 5 Issue 3 attention | automated

Continue Reading →

news

Halozyme, doubling down on a licensing strategy, buys a drug delivery biotech for nearly $1B

Dive Brief: Halozyme Therapeutics, a San Diego-based company whose business revolves around a type of drug delivery technology, announced Wednesday plans to expand...

14 April 2022 news delivery | Drug

Continue Reading →

news

Alnylam sues Pfizer, Moderna over technology used in COVID vaccines

Dive Brief: Alnylam is accusing Pfizer and Moderna of violating a patent it holds for technology that Alnylam claims the two companies use in their respective COVI...

21 March 2022 news Alnylam | COVID

Continue Reading →

news

Intellia, expanding in gene editing, buys startup Rewrite for $45M

Dive Brief: Intellia Therapeutics, a leading developer of CRISPR-based medicines, on Thursday said it will buy privately held Rewrite Therapeutics for $45 million,...

6 February 2022 news gene-editing | Intellia

Continue Reading →

news

Under pressure to share technology, Moderna to build vaccine factory in Africa

The announcement from Moderna comes amid criticism of the drugmaker, and other Western companies with authorized coronavirus vaccines, for not doing more to share the...

8 October 2021 news Africa | BioNTech

Continue Reading →

news

AstraZeneca strikes deal with university spinoff to turn RNA into drugs

The success of the mRNA vaccines developed by Moderna and BioNTech has drawn significant attention, and new funding, to the technology that allows drug developers to ...

30 September 2021 news AstraZeneca | BioNTech

Continue Reading →

Volume 4 Issue 3

Accelerating Single-Cell Genomic Sequencing with Big Memory

When fighting the global spread of a pandemic or working to fight cancer, faster time-to-discovery saves lives. For this critical bioscience work, scientists have emp...

31 August 2021 Volume 4 Issue 3 Big Memory technology | MemVerge

Continue Reading →

news

Shuwen Debuts it’s CODAR-ARMS PCR Liquid Biopsy Technology at ASCO 2018

Shuwen Biotech, a leading provider of innovative diagnostic products and medical diagnostic services, announced that studies based on its proprietary high-sensitivity...

17 May 2018 news Biopsy | Biotech

Continue Reading →

Current Edition

Upcoming Events

Advertisement

The Evolving Landscape of Academic Research Integrity

Halozyme, doubling down on a licensing strategy, buys a drug delivery biotech for nearly $1B

Alnylam sues Pfizer, Moderna over technology used in COVID vaccines

Intellia, expanding in gene editing, buys startup Rewrite for $45M

Under pressure to share technology, Moderna to build vaccine factory in Africa

AstraZeneca strikes deal with university spinoff to turn RNA into drugs

Accelerating Single-Cell Genomic Sequencing with Big Memory

Shuwen Debuts it’s CODAR-ARMS PCR Liquid Biopsy Technology at ASCO 2018

International Biopharmaceutical Industry